Followers | 1106 |
Posts | 279775 |
Boards Moderated | 10 |
Alias Born | 03/18/2011 |

Tuesday, February 28, 2012 4:32:30 AM
http://www.google.com/finance?q=TR
My stuff http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64797507
Never, invest with money you need to survive. Diversify, patience, set tight stops. $20 or less in commission fees is almost always cheaper than a 5-40%+ drop in share value.
Recent TR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 07:02:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2025 06:51:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2025 03:00:49 PM
- W. Edmund Clark, C.M. to Complete Service on Thomson Reuters' Board of Directors at AGM • PR Newswire (Canada) • 12/23/2024 12:00:00 PM
- W. Edmund Clark, C.M. to Complete Service on Thomson Reuters' Board of Directors at AGM • PR Newswire (US) • 12/23/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 04:00:28 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM